Michael Gotthardt at the Max Delbrück Center and collaborators are developing a drug to treat a common type of heart failure ...

In a study published in Neuron, a research team at the Department of Neurology at Massachusetts General Hospital, aimed to ...

RFK Jr.’s moves to limit animal testing in drug trials could pull animal rights voters into the Republican camp, experts say.

And the race is centered on one idea: transformer-based architecture with large language models are the key to winning the AI ...

Dominika Pilat, PhD, and Ana Griciuc, PhD, of the Department of Neurology at Massachusetts General Hospital are the lead and senior authors of a paper published in Neuron, "The Gain-of-Function ...

The new program is validated in a set of clinical pedigrees demonstrating its practical accuracy and relevance to the field. Collectively, the data are compelling and support the major conclusions of ...

A new study has identified a mutation in the TREM2 gene that disrupts the brain’s ability to clear toxic amyloid plaques, increasing Alzheimer’s disease risk.

The research developed by scientists at Skoltech Insitute of Science and Technology resulted in a mathematical model that ...

France’s procurement chiefs at EDF, AXA, BNP Paribas, Carrefour and TotalEnergies reveal why procurement strategy now matters ...

The drug development pipeline is a costly and lengthy process. Identifying high-quality "hit" compounds—those with high ...

The school hosted its Annual Function, 'Harmony 2025', celebrating unity, diversity and academic excellence. The event was ...